GMR Solutions Inc.

What they do

GMR Solutions provides emergent, non-emergent, disaster response and event medical services through a fleet of air and ground medical transportation assets. The company employs approximately 34,000 people, including more than 24,000 clinicians, and maintains a data set of over 80 million patient records. It serves local communities, health systems, payors and public health and government agencies, and offers solutions such as Nurse Navigation.

Revenue drivers

• Emergent and non-emergent medical services — Core EMS operations, including emergency response and interfacility transports, are the primary revenue source; net revenue was $1,490.3 million in Q2 2026, up 3.3% year-over-year.
• Air medical services — Extended-distance air transport is growing as rural hospital closures and service-line consolidation increase reliance on air medical services, per the company's stated long-term trends.
• Contracted and public-sector relationships — The company maintains longstanding relationships across health systems, payors, public health and local, state and federal agencies, which support recurring service volumes.
• Innovative care solutions — 911 Nurse Navigation and related alternate-site, out-of-hospital care offerings are cited by management as growth initiatives rather than separately disclosed revenue segments.

Recent performance

For the three months ended June 30, 2026, net revenue rose 3.3% to $1,490.3 million from $1,442.0 million a year earlier, while the company swung to a net loss of $28.3 million from net income of $80.8 million. Adjusted EBITDA fell 11.8% to $284.5 million from $322.6 million. Management attributed the year-over-year earnings decline largely to a $74.3 million difference in changes in revenue estimates, as the prior-year period benefited from unusually strong collections on No Surprises Act claims related to prior years of service. For the six months ended June 30, 2026, revenue rose 4.9% to $2,947.9 million and net income fell 34.3% to $78.1 million.

Strategy

GMR completed its initial public offering on May 14, 2026, issuing 31.9 million Class A shares at $15.00 per share for net proceeds of $446.8 million. It used capital actions to reduce leverage, repaying $670.0 million of senior secured term loan borrowings and redeeming all outstanding Series B preferred stock. The company also issued 33.3 million warrants in a private placement for gross proceeds of $500.0 million. Management's stated priorities include expanding core emergency services, securing new business wins, and advancing 911 Nurse Navigation. It reaffirmed full-year 2026 guidance.

Risks

• Revenue estimate volatility — Results are sensitive to changes in revenue estimates, and a $74.3 million year-over-year swing tied to No Surprises Act claim collections drove the Q2 2026 earnings decline.
• Elevated leverage — As of June 30, 2026, total liabilities were $6.64 billion against shareholder equity of $789.3 million, including $4.27 billion of long-term debt.
• Rural hospital closures and consolidation — Over 150 rural hospitals have closed or ceased inpatient services since 2010, with more than 300 at immediate risk, reshaping demand patterns across the company's core markets.
• Payor and reimbursement dependence — Revenue depends on collections from health systems, payors and government agencies, making results sensitive to reimbursement policy and claim resolution timing.

Outlook

Management reaffirmed full-year 2026 guidance based on results to date and its outlook for the remainder of the year, even as it noted the prior-year comparison benefited from favorable revenue estimate developments. The company reported liquidity in excess of $1.1 billion as of June 30, 2026, comprising $420.0 million of cash and cash equivalents and approximately $696.3 million of available borrowing capacity under its ABL Facility. It expects demographic aging and rural hospital consolidation to drive continued demand for emergent and air medical services, citing a projected 69 million Americans age 65 or older by 2030.